Korea Moving To Sue 104 Drug Firms, Including Some MNCs, For Selling Substandard Generics

Bioequivalence tests are conducted to compare generic versions of medicines with the originals to ascertain whether or not they are equal. These tests are especially important in South Korea, where generic drugs are the main profit drivers for many local pharmaceutical producers.

More from Archive

More from Scrip